Phase II study evaluating 68Ga-FAPI PET uptake heterogeneity as a predictor of T-DXd treatment response in HER2-positive breast cancer brain metastases.
Authors: Biyun Wang, Yannan Zhao, Zhongyi Yang, Cheng Liu
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.tps1122
Source:
Full article
Abstract
TPS1122